Atlas Trials

PREemptive Pharmacogenomic Testing for Preventing Adverse Drug REactions

Clinical trial NCT03093818 · COMPLETED

Trial details

NCT number
NCT03093818
Sponsor
J.J.Swen
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Adverse Drug Reaction
Start date
2017-03-20
Primary completion
2020-09-30
Enrollment
6950

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.